Mon, 21 Sep 2026
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025